Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
45.22 USD | +0.03% | -5.29% | +12.10% |
05-13 | Oppenheimer Adjusts Price Target on Soleno Therapeutics to $59 From $65, Maintains Outperform Rating | MT |
05-10 | Baird Starts Soleno Therapeutics With Outperform Rating, $72 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.10% | 1.65B | |
+7.30% | 113B | |
+11.14% | 106B | |
+0.32% | 22.27B | |
-11.89% | 22.22B | |
-5.99% | 19.43B | |
-37.85% | 17.87B | |
-6.32% | 17.24B | |
+7.08% | 14.29B | |
+35.16% | 12.52B |
- Stock Market
- Equities
- SLNO Stock
- News Soleno Therapeutics, Inc.
- Soleno Therapeutics Insider Sold Shares Worth $1,412,431, According to a Recent SEC Filing